Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Cash (2019 - 2025)

Historic Change in Cash for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to -$185.9 million.

  • IDEAYA Biosciences' Change in Cash rose 4117.55% to -$185.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.7 million, marking a year-over-year increase of 13947.68%. This contributed to the annual value of $28.7 million for FY2025, which is 13947.68% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Change in Cash of -$185.9 million as of Q4 2025, which was up 4117.55% from $184.3 million recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Change in Cash registered a high of $217.2 million during Q3 2024, and its lowest value of -$316.0 million during Q4 2024.
  • For the 5-year period, IDEAYA Biosciences' Change in Cash averaged around $2.1 million, with its median value being $1.9 million (2023).
  • As far as peak fluctuations go, IDEAYA Biosciences' Change in Cash soared by 453906.81% in 2021, and later crashed by 617363.06% in 2024.
  • Over the past 5 years, IDEAYA Biosciences' Change in Cash (Quarter) stood at -$16.4 million in 2021, then tumbled by 103.41% to -$33.3 million in 2022, then skyrocketed by 115.61% to $5.2 million in 2023, then tumbled by 6173.63% to -$316.0 million in 2024, then soared by 41.18% to -$185.9 million in 2025.
  • Its Change in Cash stands at -$185.9 million for Q4 2025, versus $184.3 million for Q3 2025 and -$15.4 million for Q2 2025.